BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9349988)

  • 21. Effects of intravenous infusion of amino acids on cholecystokinin release and gallbladder contraction in humans.
    Shirohara H; Tabaru A; Otsuki M
    J Gastroenterol; 1996 Aug; 31(4):572-7. PubMed ID: 8844480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
    Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of growth hormone deficiency and recombinant growth hormone therapy on postprandial gallbladder motility and cholecystokinin release.
    Moschetta A; Twickler TB; Rehfeld JF; van Ooteghem NA; Cabezas MC; Portincasa P; van Berge-Henegouwen GP; van Erpecum KJ
    Dig Dis Sci; 2004 Mar; 49(3):529-34. PubMed ID: 15139510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ethanol on meal-stimulated secretion of pancreatic polypeptide and cholecystokinin: comparison of healthy volunteers, heavy drinkers, and patients with chronic pancreatitis.
    Hirano H; Shimosegawa T; Meguro T; Shiga N; Koizumi M; Toyota T
    J Gastroenterol; 1996 Feb; 31(1):86-93. PubMed ID: 8808434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholestyramine influences meal-stimulated pancreaticobiliary function and plasma cholecystokinin independent of gastric emptying and food digestion.
    Thimister PW; Hopman WP; Loualidi A; Rosenbusch G; Willems HL; Trijbels FJ; Jansen JB
    Scand J Gastroenterol; 1997 Aug; 32(8):778-84. PubMed ID: 9282969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gallbladder motility in Crohn disease: influence of disease localization and bowel resection.
    Vu MK; Gielkens HA; van Hogezand RA; van Oostayen JA; Lamers CB; Masclee AA
    Scand J Gastroenterol; 2000 Nov; 35(11):1157-62. PubMed ID: 11145286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholecystokinin, secretin, pancreatic polypeptide in relation to gallbladder dynamics and gastrointestinal interdigestive motility.
    Qvist N; Oster-Jørgensen E; Rasmussen L; Pedersen SA; Olsen O; Cantor P; Schaffalitzky de Muckadell OB
    Digestion; 1990; 45(3):130-7. PubMed ID: 2373268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in cholecystokinin release and gallbladder contraction between emulsified and nonemulsified long-chain triglycerides.
    Ledeboer M; Masclee AA; Biemond I; Lamers CB
    JPEN J Parenter Enteral Nutr; 1999; 23(4):203-6. PubMed ID: 10421388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis.
    Pompili M; Rapaccini GL; Caturelli E; Curró D; Montuschi P; D'Amato M; Aliotta A; Grattagliano A; Cedrone A; Anti M
    Dig Dis Sci; 1995 Feb; 40(2):428-34. PubMed ID: 7851211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postprandial gall bladder motility and hormone release during intermittent and continuous subcutaneous octreotide treatment in acromegaly.
    Stolk MF; van Erpecum KJ; Koppeschaar HP; de Bruin WI; Jansen JB; Lamers CB; van Berge Henegouwen GP
    Gut; 1993 Jun; 34(6):808-13. PubMed ID: 8314514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
    Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
    J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma cholecystokinin and pancreatic polypeptide responses after ingestion of a liquid test meal rich in medium-chain fatty acids in patients with chronic pancreatitis.
    Nakano I; Funakoshi A; Shinozaki H; Sakai K
    Am J Clin Nutr; 1989 Feb; 49(2):247-51. PubMed ID: 2916444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma CCK levels in patients with pancreatic insufficiency.
    Bozkurt T; Adler G; Koop I; Koop H; Türmer W; Arnold R
    Dig Dis Sci; 1988 Mar; 33(3):276-81. PubMed ID: 3342719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fasting and meal-induced CCK and PP secretion following intragastric balloon treatment for obesity.
    Mathus-Vliegen EM; de Groot GH
    Obes Surg; 2013 May; 23(5):622-33. PubMed ID: 23224567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cholecystokinin receptor blockade on circulating concentrations of glucose, insulin, C-peptide, and pancreatic polypeptide after various meals in healthy human volunteers.
    Niederau C; Schwarzendrube J; Lüthen R; Niederau M; Strohmeyer G; Rovati L
    Pancreas; 1992; 7(1):1-10. PubMed ID: 1557335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Gettys TW; Taylor IL; Rushakoff RJ; Williams VC; Coker LD
    J Clin Endocrinol Metab; 1990 May; 70(5):1312-8. PubMed ID: 2186058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma cholecystokinin levels and gallbladder volumes after proctocolectomy with ileal pouch-anal anastomosis.
    Salemans JM; Thimister PW; Hopman WP; Kuijpers HC; Rosenbusch G; Nagengast FM; Jansen JB
    Surgery; 1995 Jun; 117(6):705-11. PubMed ID: 7778034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orlistat reduces gallbladder emptying by inhibition of CCK release in response to a test meal.
    Ellrichmann M; Ritter PR; Otte JM; Schrader H; Banasch M; Brunke G; Herzig KH; Seebeck J; Schmidt WE; Schmitz F
    Regul Pept; 2007 Mar; 139(1-3):136-40. PubMed ID: 17175037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs.
    Rehfeld JF; Knop FK; Asmar A; Madsbad S; Holst JJ; Asmar M
    Scand J Gastroenterol; 2018 Dec; 53(12):1429-1432. PubMed ID: 30449207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of orlistat on the regulation of gallbladder contraction in man: a randomized double-blind placebo-controlled crossover study.
    Froehlich F; Hartmann D; Guezelhan C; Gonvers JJ; Jansen JB; Fried M
    Dig Dis Sci; 1996 Dec; 41(12):2404-8. PubMed ID: 9011450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.